Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02738775
Brief Title: Phase IIa Study of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis

First Submitted : April 10, 2016
First Submitted that Met QC Criteria : April 11, 2016
First Posted : April 14, 2016 (Estimate)

Results First Submitted : June 22, 2021
Results First Submitted that Met QC Criteria : June 22, 2021
Results First Posted : July 15, 2021

Last Update Submitted that Met QC Criteria : June 22, 2021
Last Update Posted : July 15, 2021